Biosimilar Development Process

Biological products that are demonstrated to be biosimilar to or interchangeable with an FDA-approved biological product

  • Abbreviated pathway to provide more treatment options, increase access, lower costs
  • Rigorous approval standards for  safety and effectiveness
  • Ten biosmilars approved to date

Learning toolkit to help promote understanding of biosimilars and interchangeable products


Image credit: FDA


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s